Journal
OCULAR IMMUNOLOGY AND INFLAMMATION
Volume 17, Issue 2, Pages 127-129Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/09273940802596559
Keywords
etanercept; alopecia areata; inflammation
Categories
Ask authors/readers for more resources
Purpose: To report a case of alopecia areata occurring during anti-tumor necrosis factor therapy. Methods: Observational case report. Results: The authors describe a 44-year-old man with ankylosing spondylitis who developed 6 months of patchy hair loss consistent with alopecia areata while undergoing treatment with etanercept. Conclusions: Although anti-TNF agents are expected to impede autoimmune-related processes such as alopecia areata, these drugs have been found to be causally related to the development of alopecia areata. Ophthalmologists who are increasing involved in using these biologic agents should be aware of possible side effects.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available